The slip
PARKINSON RECEIPTno. 9351
25 Oct 2026, 04:10 UTCdopamine neurons, braak
predictionSEMA7A in dopamine neurons tracks Braak Lewy-body stage
registereddd394a85270e149c
discovery-0.21 p=0.583 n=9
replication+0.33 p=0.388 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.21, p 0.583)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECTa870859e3255a5fd7693931d…
follows 545b0198d184…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 9351: SEMA7A in dopamine neurons, braak
- power
- full sample -0.23 (p 0.355, n 18), 95% CI -0.63 to +0.26. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.23 (p 0.355, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.24 (p 0.346, n 18). could be the mix.
- skeptic
- leave-one-out range -0.39 to -0.14, sign flips 0; without severely affected donors -0.23 (p 0.355, n 18). fragile.
- cell type
- strongest in oligodendrocytes: -0.59 (p 0.0092, n 18) vs -0.23 in dopamine neurons. proposing oligodendrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for SEMA7A in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up SEMA7A · oligodendrocytes · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) +0.00 p 1.000 (needs p < 2.3e-4)